These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20953120)

  • 1. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
    Satoh J
    J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
    Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular network of microRNA targets in Alzheimer's disease brains.
    Satoh J
    Exp Neurol; 2012 Jun; 235(2):436-46. PubMed ID: 21945006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer's Disease.
    Keifer J; Zheng Z; Ambigapathy G
    Microrna; 2015; 4(2):101-8. PubMed ID: 26456533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroepigenetics of memory formation and impairment: the role of microRNAs.
    Saab BJ; Mansuy IM
    Neuropharmacology; 2014 May; 80():61-9. PubMed ID: 24486712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in glaucoma and neurodegenerative diseases.
    Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
    J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
    Qiu L; Zhang W; Tan EK; Zeng L
    ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's Disease.
    Garza-Manero S; Pichardo-Casas I; Arias C; Vaca L; Zepeda A
    Brain Res; 2014 Oct; 1584():80-93. PubMed ID: 24355599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
    Salta E; De Strooper B
    FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
    Millan MJ
    Prog Neurobiol; 2017 Sep; 156():1-68. PubMed ID: 28322921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for MIND: microRNAs in neurodegenerative diseases.
    Barbato C; Ruberti F; Cogoni C
    J Biomed Biotechnol; 2009; 2009():871313. PubMed ID: 19707536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the roles and regulation of mitochondrial microRNAs (MitomiRs) in neurodegenerative diseases: Current status and advances.
    Saikia BJ; Bhardwaj J; Paul S; Sharma S; Neog A; Paul SR; Bk B
    Mech Ageing Dev; 2023 Jul; 213():111838. PubMed ID: 37329989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
    Nunomura A; Perry G
    Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs (miRNAs) in neurodegenerative diseases.
    Nelson PT; Wang WX; Rajeev BW
    Brain Pathol; 2008 Jan; 18(1):130-8. PubMed ID: 18226108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
    Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
    J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular mechanism of translational control via the communication between the microRNA pathway and RNA-binding proteins.
    Fukao A; Aoyama T; Fujiwara T
    RNA Biol; 2015; 12(9):922-6. PubMed ID: 26274611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.